Member Info for Kong1

Reading the story of the accuracy of the LFT test on the BBC

Some professor described the test like apples & Oranges.
Did Alastair not say this in one of his podcasts where he got a little confused and blurted out the comparison between apples & oranges when discussing our test against the rest.
So they are fully aware of Avacta without mentioning our name in public !!!!

Mowzerrocks
Every share that has exiting prospects will always have posters like wyndrum.
I’ve seen it so many times.
There will always be the opposite. Some will not have a bad word said.
The two types of posters are as dangerous as each other

Canetoad I bought at 1.77

I thought it had bottomed then, but alas it hadn’t.
Well done to all that bought at £1.60

Mickey your sadly mistaken
I have given constructive criticism and stated the truth,
I am invested here and a fool who only believes in positive posts rather than trying to see all aspects is the real fool.
I should have sold a few when we hit the highs of £2.70, but I kept the faith and listened and followed the likes of you.
My mistake
Have a good day !

I’ve been here for for 18 months . I’ve followed them and taken all the RNS as very positive, however I’m feeling quite disappointed in the direction the company took in making a test best in class for professional use only when possibly more money was to be made for a test that was for home use.
I’m sure Alistar mentioned they was working on a home test but surely the boat has sailed now !!!
The millions of tests reportedly mentioned that would be need for years to come just don’t seem to be materialising.
Time scales and products have just not happened.
I would really like to know what Benifit the covid dilemma will give the company in regards to revenue.

The diagnostic division with the huge amounts of money involved world wide seems to have taken a back step.
Very little news has come from Avacta considering what a brilliant product we seem to have.
You would have thought companies throughout the world would be clambering all over Avacta wanting to use their patent and highly regarded affirmers.

So now we are left with the cancer therapy, I’m really hoping we will have positive news but to me this has all been overshadowed by the lack of news, direction and self belief what I thought was going to come from the company.

Alistar needs to address some of the negativity that has been developing over the last few months.

Paddyboy
Your wasting your money
Have you worked out how much this has got to go up to make a small profit after youve taken your costs out of the equation

I’m hoping we have reached bottom and start to climb the stairs again
Would be very happy if we can get back to the £2.00 mark

Mr bond007
Couldn’t agree more. After seeing the results I thought this was going go up quite a bit.
The results look pretty impressive, but obviously not otherwise SP would be quite a bit higher
Not quite sure what to make of it now

I was only thinking of him today and where he was

i`m guessing with the manipulation of todays drop, and the large order filled, i think we might have a rise tomorrow in aniticipation of possibly RNS monday and todays antics

i`ll be suprised of another drop

pigster

our test is not a home test, ours are for proffessional use only, thats one reason why we are not selling the amounts we`d like to

Marik

A genuine question please

If an institution wants a large buy, will there dictate the price or will MMs sweeten the offer to get the large buy so to get their commission so they drop the price on purpose ?

Mradventura
Yes I totally understand the trial, but they are studying the treatment to see if a number of findings in the mice are the same in humans.
So if the findings are very good regarding toxicity in the organs then we go on to the next stage, but however you look at it, it’s a treatment . Science is just trying to see if the treatment ticks all the boxes . Period !
All we have to do now is wait until Q2 2022 to see the findings. Only then will the excitement change

Mradventurous

Of course it’s a treatment study, why are they doing this study otherwise ?

Now why would he do that when things should be just starting to get juicy
That dosent bode well

I’m really struggling to understand why no news of any sales whatsoever.
It’s been 6 weeks since we got our CE markings, upon which it was stated it can be sold straight away,
we also have had confirmation that it picks up the delta variant better than any other product on the market.
We’ve officially got the finest test available in the world.
AS has made it clear we are going to sell the tests and help with sustaining the bank balance .
So where the bloody hell are the orders ?
I am struggling to understand why we’ve not had any news on orders.
And regarding the diagnostic side of the buisiness the news coming from that side is just as defining

We have taken a battering for sure.
AS presents himself and the company in an exemplary manner.
He talks and explains questions in a fantastic way that others struggles with.
The thing that has let us down is time scales and targets.
I for one said that once we get C.E markings the orders would be there instantly because we were and are talking to many governments and organisations.
So a few weeks down the line and we are still waiting for news on orders ?
I am struggling to come to terms on this one. We also don’t have a self testing kit just a professional one, so why wasn’t this worked on over the last 14 months .
AVA 6000
First we was going to be in clinic early 2021, then June, now it appears to be July but we are still waiting.
No other news on diognostics and yet this side of the business could be worth billions.
I very much like AS and Avacta but we haven’t covered ourselves in glory of late.
I really do hope news is imminent and this has just been a minor hiccup

It is interesting to note that there is no mention of novact test that says it can detect the delta variant, if it can’t then it’s virtually useless
Avacta has proved that we can detect every variant so far.

No one will buy a test that can’t identify all variants, it would be just a waste of tax payers money

Avacta will be the only one anyone should buy.

We just need the orders to confirm what the reality is.

Avacta SIMPLY THE BEST. !!!!!

Matml74

The share price is where it is because no significant news has given this company a direction.
The markets need to know where we are going , what are capacity is and some idea of revenue.
The share price has gone up due to hype. But over this last week the share price has nose dived due to lack of information.
For the share price to recover we need to know more hard facts, about the numbers of units available, the number of units that can be manufactured per week, and what are the sales going to be like and revenue.
We also would like to know where we are with the cancer trials.
All this information drives share price, without it the share price will falter and that’s why it’s come down over this last week or so.
Stability and visibility is what the markets need fir the share price to recover

Timster I agree
The news is very welcome, but I’d like to know what we have manufactured so far, what we have in stock, and what is our capacity now and if we have any views of expanding our capacity and after talking to governments and companies what are the numbers like going forward for the next 12 months
I think we have waited long enough now for more solid figures that we can work with, giving us a little more insight into the numbers Avacta might be able to generate